Empagliflozin improves cardiovascular outcomes in patients with heart failure, patients with type 2 diabetes who are at high cardiovascular risk, and patients with chronic kidney disease. The safety ...
Slower heart rate recovery before PCI independently predicts periprocedural myocardial infarction and may improve cardiac risk assessment.
A strategy of administering a transfusion only when the hemoglobin level falls below 7 or 8 g per deciliter has been widely adopted. However, patients with acute myocardial infarction may benefit from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback